WebNOVACYT : Press releases relating to NOVACYT Investor relations Deutsche Boerse AG: NYZ Deutsche Boerse AG WebFeb 10, 2024 · Investor Relations Novacyt SA ALNOV Ownership Morningstar Rating Rating as of Feb 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ...

Mandy Cowling - Corporate & Investor Relations Manager

WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the ticker LSE:NCYT . NOVACYT is funded by 4 investors. Kreos Capital and YA Global Master SPV are the most recent investors. NOVACYT has acquired 4 organizations. WebNovacyt, founded in 2006, by an experimented team coming from biotech and industrial companies, is active in developing, manufacturing and marketing advanced and innovative solutions for cytology. Use the CB Insights Platform to explore Novacyt's full profile. ... Who are the investors of Novacyt? Investors of Novacyt include Wilco. dysfunctional uterine bleeding perimenopause

NOVACYT - Crunchbase Company Profile & Funding

WebSep 29, 2024 · Appointed CEO of Novacyt in 2024 Over 25 years of global experience in pharmaceuticals & biopharmaceutical companies Internationally experienced, strategic … WebNovacyt Group. Jan 2024 - Present5 years 2 months. Cambridge & Camberley. The Corporate & Investor Relations Manager is a multi … WebNovacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. They are passionate about their business and the healthcare industry sector they work with and would like to thank you for your ... csc blythewood sc jobs